Role of biologics in intractable urticaria

References

• ZuberbierTAbererWAseroREuropean Academy of Allergy and Clinical ImmunologyGlobal Allergy and Asthma European NetworkEuropean Dermatology Forum; World Allergy OrganizationThe EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and updateAllergy201469786888724785199
   PubMed Web of Science ®Google Scholar
• O’DonnellBFLawlorFSimpsonJMorganMGreavesMWThe impact of chronic urticaria on the quality of lifeBr J Dermatol199713621972019068731
   PubMed Web of Science ®Google Scholar
• KhanDAChronic urticaria: diagnosis and managementAllergy Asthma Proc200829543944618926051
   PubMed Web of Science ®Google Scholar
• EnginBUguzFYilmazEOzdemirMMevlitogluIThe levels of depression, anxiety and quality of life in patients with chronic idiopathic urticariaJ Eur Acad Dermatol Venereol2008221364018181971
   PubMed Web of Science ®Google Scholar
• KaplanAPTreatment of chronic spontaneous urticariaAllergy Asthma Immunol Res20124632633123115728
   PubMed Web of Science ®Google Scholar
• PowellRJDu ToitGLSiddiqueNBritish Society for Allergy and Clinical Immunology (BSACI)BSACI guidelines for the management of chronic urticaria and angio-oedemaClin Exp Allergy200737563165017456211
   PubMed Web of Science ®Google Scholar
• GreavesMChronic urticariaJ Allergy Clin Immunol2000105466467210756214
   PubMed Web of Science ®Google Scholar
• MaurerMWellerKBindslev-JensenCUnmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force reportAllergy201166331733021083565
   PubMed Web of Science ®Google Scholar
• BernsteinJALangDMKhanDAThe diagnosis and management of acute and chronic urticaria: 2014 updateJ Allergy Clin Immunol201413351270127724766875
   PubMed Web of Science ®Google Scholar
• HumphreysFHunterJAThe characteristics of urticaria in 390 patientsBr J Dermatol199813846356389640369
   PubMed Web of Science ®Google Scholar
• NormansellRWalkerSMilanSJWaltersEHNairPOmalizumab for asthma in adults and childrenCochrane Database Syst Rev20141CD00355924414989
   PubMed Web of Science ®Google Scholar
• EasthopeSJarvisBOmalizumabDrugs2001612253260 discussion 26111270941
   PubMed Web of Science ®Google Scholar
• KaplanAPTherapy of chronic urticaria: a simple, modern approachAnn Allergy Asthma Immunol2014112541942524656924
   PubMed Web of Science ®Google Scholar
• NiimiNFrancisDMKermaniFDermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticariaJ Invest Dermatol19961065100110068618029
   PubMed Web of Science ®Google Scholar
• HolgateSTDjukanovicRCasaleTBousquetJAnti- immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacyClin Exp Allergy200535440841615836747
   PubMed Web of Science ®Google Scholar
• SaavedraMCSurSDown regulation of the high-affinity IgE receptor associated with successful treatment of chronic idiopathic urticaria with omalizumabClin Mol Allergy201191221247438
   PubMedGoogle Scholar
• ChangTWChenCLinCJMetzMChurchMKMaurerMThe potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticariaJ Allergy Clin Immunol20151352337342.e224948369
   PubMed Web of Science ®Google Scholar
• KawakamiTGalliSJRegulation of mast-cell and basophil function and survival by IgENat Rev Immunol200221077378612360215
   PubMed Web of Science ®Google Scholar
• BoyceJASuccessful treatment of cold-induced urticaria/anaphylaxis with anti-IgEJ Allergy Clin Immunol200611761415141816751006
   PubMed Web of Science ®Google Scholar
• SandsMFBlumeJWSchwartzSASuccessful treatment of 3 patients with recurrent idiopathic angioedema with omalizumabJ Allergy Clin Immunol2007120497998117931567
   PubMed Web of Science ®Google Scholar
• SpectorSLTanRAEffect of omalizumab on patients with chronic urticariaAnn Allergy Asthma Immunol200799219019317718108
   PubMed Web of Science ®Google Scholar
• VestergaardCDeleuranMTwo cases of severe refractory chronic idiopathic urticaria treated with omalizumabActa Derm Venereol201090444344420574627
   PubMed Web of Science ®Google Scholar
• RomanoCSellittoADe FanisUMaintenance of remission with low-dose omalizumab in long-lasting, refractory chronic urticariaAnn Allergy Asthma Immunol20101041959720143654
   PubMed Web of Science ®Google Scholar
• MetzMOhanyanTChurchMKMaurerMOmalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysisJ Dermatol Sci2014731576224060603
   PubMed Web of Science ®Google Scholar
• AltmanMCNaimiDROmalizumab for chronic urticariaN Engl J Med2013368262528253023802532
   PubMedGoogle Scholar
• BrodskaPSchmid-GrendelmeierPTreatment of severe cold contact urticaria with omalizumab: case reportsCase Rep Dermatol20124327528023341807
   PubMedGoogle Scholar
• SainiSSBindslev-JensenCMaurerMEfficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H antihistamines: a randomized, placebo-controlled studyJ Invest Dermatol20151351677525046337
   PubMed Web of Science ®Google Scholar
• MetzMBergmannPZuberbierTMaurerMSuccessful treatment of cholinergic urticaria with anti-immunoglobulin E therapyAllergy200863224724918186820
   PubMed Web of Science ®Google Scholar
• KaplanAPJosephKMaykutRJGebaGPZeldinRKTreatment of chronic autoimmune urticaria with omalizumabJ Allergy Clin Immunol2008122356957318774392
   PubMed Web of Science ®Google Scholar
• MaurerMAltrichterSBieberTEfficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidaseJ Allergy Clin Immunol20111281202209.e521636116
   PubMed Web of Science ®Google Scholar
• SainiSRosenKEHsiehHJA randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticariaJ Allergy Clin Immunol20111283567573.e121762974
   PubMed Web of Science ®Google Scholar
• MaurerMRosenKHsiehHJOmalizumab for the treatment of chronic idiopathic or spontaneous urticariaN Engl J Med20133681092493523432142
   PubMed Web of Science ®Google Scholar
• KaplanALedfordDAshbyMOmalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapyJ Allergy Clin Immunol2013132110110923810097
   PubMed Web of Science ®Google Scholar
• BernsteinJASainiSSMaurerMEfficacy of omalizumab in patients with chronic idiopathic/spontaneous urticaria with different background therapy: post hoc analysis of ASTERIA I, ASTERIA II, and GLACIAL studiesJ Allergy Clin Immunol20141332 SupplAB117
   Web of Science ®Google Scholar
• MetzMOhanyanTChurchMKMaurerMRetreatment with omalizumab results in rapid remission in chronic spontaneous and inducible urticariaJAMA Dermatol2014150328829024477320
   PubMed Web of Science ®Google Scholar
• SchwabINimmerjahnFIntravenous immunoglobulin therapy: how does IgG modulate the immune system?Nat Rev Immunol201313317618923411799
   PubMed Web of Science ®Google Scholar
• BallowMMechanisms of immune regulation by IVIGCurr Opin Allergy Clin Immunol201414650951525337683
   PubMed Web of Science ®Google Scholar
• NegiVSElluruSSiberilSIntravenous immunoglobulin: an update on the clinical use and mechanisms of actionJ Clin Immunol200727323324517351760
   PubMed Web of Science ®Google Scholar
• BallowMThe IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disordersJ Allergy Clin Immunol20111272315323 quiz 324–31521185071
   PubMed Web of Science ®Google Scholar
• NeunertCLimWCrowtherMCohenASolbergLJrCrowtherMAAmerican Society of HematologyThe American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopeniaBlood2011117164190420721325604
   PubMed Web of Science ®Google Scholar
• O’DonnellBFBarrRMBlackAKIntravenous immunoglobulin in autoimmune chronic urticariaBr J Dermatol199813811011069536230
   PubMed Web of Science ®Google Scholar
• WatkinsCPeirisESalehHKrishnaswamyGIntravenous immunoglobulin as a potential therapy for refractory urticaria – a reviewInflamm Allergy Drug Targets201211537538122594611
   PubMedGoogle Scholar
• HideMFrancisDMGrattanCEHakimiJKochanJPGreavesMWAutoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticariaN Engl J Med199332822159916047683772
   PubMed Web of Science ®Google Scholar
• GrattanCEFrancisDMSlaterNGBarlowRJGreavesMWPlasmapheresis for severe, unremitting, chronic urticariaLancet19923398801107810801373787
   PubMed Web of Science ®Google Scholar
• PereiraCTavaresBCarrapatosoILow-dose intravenous gammaglobulin in the treatment of severe autoimmune urticariaEur Ann Allergy Clin Immunol200739723724218237000
   PubMedGoogle Scholar
• AseroRAre IVIG for chronic unremitting urticaria effective?Allergy200055111099110111097330
   PubMed Web of Science ®Google Scholar
• CorreiaISilvaJFilipePGomesMSolar urticaria treated successfully with intravenous high-dose immunoglobulin: a case reportPhotodermatol Photoimmunol Photomed200824633033119000192
   PubMed Web of Science ®Google Scholar
• DarrasSSegardMMortierLBonnevalleAThomasPUrticaire solaire traitée par l’association immunoglobulines polyvalentes et PUVAthérapie. [Treatment of solar urticaria by intravenous immunoglobulins and PUVA therapy]Ann Dermatol Venereol20041311 Pt 16569 French15041848
   PubMed Web of Science ®Google Scholar
• AubinFPorcherRJeanmouginMSociété Française de PhotodermatologieSevere and refractory solar urticaria treated with intravenous immunoglobulins: a phase II multicenter studyJ Am Acad Dermatol2014715948953.e125135650
   PubMed Web of Science ®Google Scholar
• MallipeddiRGrattanCELack of response of severe steroid-dependent chronic urticaria to rituximabClin Exp Dermatol200732333333417397362
   PubMed Web of Science ®Google Scholar
• ArkwrightPDAnti-CD20 or anti-IgE therapy for severe chronic autoimmune urticariaJ Allergy Clin Immunol20091232510511 author reply 51119203667
   PubMed Web of Science ®Google Scholar
• ChakravartySDYeeAFPagetSARituximab successfully treats refractory chronic autoimmune urticaria caused by IgE receptor autoantibodiesJ Allergy Clin Immunol201112861354135521958584
   PubMed Web of Science ®Google Scholar
• SaigalKValenciaICCohenJKerdelFAHypocomplementemic urticarial vasculitis with angioedema, a rare presentation of systemic lupus erythematosus: rapid response to rituximabJ Am Acad Dermatol2003495 SupplS283S28514576655
   PubMed Web of Science ®Google Scholar
• HermesBProchazkaAKHaasNJurgovskyKSticherlingMHenzBMUpregulation of TNF-alpha and IL-3 expression in lesional and uninvolved skin in different types of urticariaJ Allergy Clin Immunol19991032 Pt 13073149949323
   PubMed Web of Science ®Google Scholar
• PiconiSTrabattoniDIemoliEImmune profiles of patients with chronic idiopathic urticariaInt Arch Allergy Immunol20021281596612037402
   PubMed Web of Science ®Google Scholar
• MagerlMPhilippSManasterskiMFriedrichMMaurerMSuccessful treatment of delayed pressure urticaria with anti-TNF-alphaJ Allergy Clin Immunol2007119375275417336621
   PubMed Web of Science ®Google Scholar
• WilsonLHEliasonMJLeifermanKMHullCMPowellDLTreatment of refractory chronic urticaria with tumor necrosis factor-alfa inhibitorsJ Am Acad Dermatol20116461221122221571206
   PubMed Web of Science ®Google Scholar
• HannumCHWilcoxCJArendWPInterleukin-1 receptor antagonist activity of a human interleukin-1 inhibitorNature199034362563363402137200
   PubMed Web of Science ®Google Scholar
• AltenRGramHJoostenLAThe human anti-IL-1 beta monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritisArthritis Res Ther2008103R6718534016
   PubMed Web of Science ®Google Scholar
• FedericiSSormaniMPOzenSfor the Paediatric Rheumatology International Trials Organisation (PRINTO) and Eurofever ProjectEvidence-based provisional clinical classification criteria for autoinflammatory periodic feversAnn Rheumat Dis Epub1302015
   Web of Science ®Google Scholar
• HoffmanHMMuellerJLBroideDHWandererAAKolodnerRDMutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndromeNat Genet200129330130511687797
   PubMed Web of Science ®Google Scholar
• ChurchLDCookGPMcDermottMFPrimer: inflammasomes and interleukin 1beta in inflammatory disordersNat Clin Pract Rheumatol200841344218172447
   PubMedGoogle Scholar
• LachmannHJKone-PautIKuemmerle-DeschnerJBUse of canakinumab in the cryopyrin-associated periodic syndromeN Engl J Med2009360232416242519494217
   PubMed Web of Science ®Google Scholar
• SimonAAsliBBraun-FalcoMSchnitzler’s syndrome: diagnosis, treatment, and follow-upAllergy201368556256823480774
   PubMed Web of Science ®Google Scholar
• LipskerDThe Schnitzler syndromeOrphanet J Rare Dis201053821143856
   PubMed Web of Science ®Google Scholar
• LachmannHJHawkinsPNDevelopments in the scientific and clinical understanding of autoinflammatory disordersArthritis Res Ther200911121219232070
   PubMed Web of Science ®Google Scholar
• NeelAHenryBBarbarotSLong-term effectiveness and safety of interleukin-1 receptor antagonist (anakinra) in Schnitzler’s syndrome: a French multicenter studyAutoimmun Rev201413101035104125220180
   PubMed Web of Science ®Google Scholar
• MertensMSinghJAAnakinra for rheumatoid arthritisCochrane Database Syst Rev20091CD00512119160248
   PubMed Web of Science ®Google Scholar